NCT03037086View on ClinicalTrials.gov

Asia PDL1 Study Among NSCLC Patients

CompletedOBSERVATIONAL

Enrollment

658

Participants

Timeline

Start Date

October 15, 2015

Primary Completion Date

February 27, 2017

Study Completion Date

February 27, 2017

Conditions

Locally Advanced or Metastatic NSCLC

Trial Locations (4)

Unknown

Research Site, Guangzhou

Research Site, Iizuka-shi

Research Site, Fukushima

Research Site, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY